Hepatitis C Virus Therapy
Recent findings in hepatitis C virus therapy described by researchers from Erasmus University
Published in Hepatitis Weekly, March 9th, 2009
Data detailed in 'What is on the horizon for treatment of chronic hepatitis C' have been presented. "Current guidelines for chronic Hepatitis C recommend peginterferon-alpha and ribavirin combination therapy for 24 or 48 weeks, based on viral factors (genotype, viral load), host factors (stage of liver disease) and virological response during treatment. The main goal of treatment is eradication of Hepatitis C virus (HCV) infection which is defined by HCV RNA negativity 24 weeks after end of treatment (i.e. sustained virological response, SVR)," researchers in Rotterdam, Netherlands report.
"SVR can be achieved in up to 80% of patients. Most patients, however, experience...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-03-09)
More Articles from Hepatitis Weekly
- Acute Hepatitis
Findings from INSERM advance knowledge in acute hepatitis - Antivirals
Study results from M. Baril and colleagues update understanding of antivirals - Hepatitis
New hepatitis study findings have been reported from Center for Satellite Applications and Research - Hepatitis A Virus
Research from Tampere University yields new findings on hepatitis A virus - Hepatitis B Virus
New findings from Shandong University in the area of hepatitis B virus published - Hepatitis B Virus
New findings from Z.S. Zou and co-authors in the area of hepatitis B virus published - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
